These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19733652)

  • 1. Is the medication used to achieve the target intraocular pressure in glaucoma therapy of relevance?--an exemplary analysis on the basis of two beta-blockers.
    Grieshaber MC; Flammer J
    Prog Retin Eye Res; 2010 Jan; 29(1):79-93. PubMed ID: 19733652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of the effectiveness of beta-blockers for intraocular pressure and visual field in primary open-angle glaucoma].
    Dobre X
    Oftalmologia; 2008; 52(4):95-9. PubMed ID: 19354170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.
    Reis R; Queiroz CF; Santos LC; Avila MP; Magacho L
    Clin Ther; 2006 Apr; 28(4):552-9. PubMed ID: 16750466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing antiglaucoma therapy from timolol to betaxolol: effect on ocular blood flow.
    Rainer G; Dorner GT; Garhöfer G; Vass C; Pfleger T; Schmetterer L
    Ophthalmologica; 2003; 217(4):288-93. PubMed ID: 12792136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.
    Martínez A; Sánchez M
    Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with COSOPT, the fixed combination of timolol and dorzolamide, gained in Swiss ophthalmologists' offices.
    Pajic B;
    Curr Med Res Opin; 2003; 19(2):95-101. PubMed ID: 12740152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effect of ophthalmic beta-adrenoceptor antagonists on intraocular pressure and retinal sensitivity in primary open-angle glaucoma.
    Collignon-Brach J
    Curr Eye Res; 1992 Jan; 11(1):1-3. PubMed ID: 1559386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 7 year prospective comparative study of three topical beta blockers in the management of primary open angle glaucoma.
    Watson PG; Barnett MF; Parker V; Haybittle J
    Br J Ophthalmol; 2001 Aug; 85(8):962-8. PubMed ID: 11466256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of levobetaxolol and timolol at blunting retinal ischaemia is related to their calcium and sodium blocking activities: relevance to glaucoma.
    Osborne NN; Wood JP; Chidlow G; Casson R; DeSantis L; Schmidt KG
    Brain Res Bull; 2004 Feb; 62(6):525-8. PubMed ID: 15036567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Visual field and intraocular pressure asymmetry in the low-pressure glaucoma treatment study.
    Greenfield DS; Liebmann JM; Ritch R; Krupin T;
    Ophthalmology; 2007 Mar; 114(3):460-5. PubMed ID: 17141318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of ophthalmic beta-blocking agents.
    Lesar TS
    Clin Pharm; 1987 Jun; 6(6):451-63. PubMed ID: 2891463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Timolol treatment prevents or delays glaucomatous visual field loss in individuals with ocular hypertension: a five-year, randomized, double-masked, clinical trial.
    Kass MA
    Trans Am Ophthalmol Soc; 1989; 87():598-618. PubMed ID: 2562546
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A three-year prospective, randomized and open comparison between latanoprost and timolol in Japanese normal-tension glaucoma patients.
    Tomita G; Araie M; Kitazawa Y; Tsukahara S
    Eye (Lond); 2004 Oct; 18(10):984-9. PubMed ID: 15037889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components.
    Strohmaier K; Snyder E; DuBiner H; Adamsons I
    Ophthalmology; 1999 Dec; 106(12 Suppl):1-9. PubMed ID: 10598691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term tolerability of once-daily timolol hemihydrate 0.5%, timolol maleate in sorbate 0.5%, and generic timolol maleate gel-forming solution 0.5% in glaucoma and/or ocular hypertension: a prospective, randomized, double-masked, active-controlled, three-period crossover pilot study.
    Sonty S; Mundorf TK; Stewart JA; Stewart WC
    Clin Ther; 2009 Oct; 31(10):2063-71. PubMed ID: 19922877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A long-term study of the visual fields in patients treated with betaxolol and timolol].
    Flammer J; Collignon-Brach J; Demailly P; Graves SA
    Oftalmologia; 1998; 42(1):77-82; discussion 82-3. PubMed ID: 9713206
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-term efficacy and safety of bimatoprost for intraocular pressure lowering in glaucoma and ocular hypertension: year 4.
    Williams RD; Cohen JS; Gross RL; Liu CC; Safyan E; Batoosingh AL;
    Br J Ophthalmol; 2008 Oct; 92(10):1387-92. PubMed ID: 18621791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraocular pressure-lowering effects of all commonly used glaucoma drugs: a meta-analysis of randomized clinical trials.
    van der Valk R; Webers CA; Schouten JS; Zeegers MP; Hendrikse F; Prins MH
    Ophthalmology; 2005 Jul; 112(7):1177-85. PubMed ID: 15921747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression of retinal nerve fibre layer damage in betaxolol- and timolol-treated glaucoma patients.
    Vainio-Jylhä E; Vuori ML; Nummelin K
    Acta Ophthalmol Scand; 2002 Oct; 80(5):495-500. PubMed ID: 12390160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of 2% dorzolamide on retinal blood flow: a study on juvenile primary open-angle glaucoma patients already receiving 0.5% timolol.
    Costagliola C; Campa C; Parmeggiani F; Incorvaia C; Perri P; D'Angelo S; Lamberti G; Sebastiani A
    Br J Clin Pharmacol; 2007 Mar; 63(3):376-9. PubMed ID: 16981897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.